So-Young International Inc (SY)
0.9047
+0.10
(+13.13%)
USD |
NASDAQ |
Nov 14, 11:49
So-Young International Debt to Equity Ratio: 0.0164 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.0164 |
| March 31, 2024 | 0.0124 |
| December 31, 2023 | 0.0122 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
0.0164
Maximum
Jun 2024
0.0022
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Sinovac Biotech Ltd | 0.0358 |
| CASI Pharmaceuticals Inc | 2.047 |
| Zai Lab Ltd | 0.0998 |
| Adagene Inc | -- |
| LakeShore Biopharma Co Ltd | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 444.68M |
| Total Liabilities (Quarterly) | 94.50M |
| Shareholders Equity (Quarterly) | 333.75M |
| Current Ratio | 3.164 |
| Net Debt Paydown Yield | -1.01% |